上海莱士控股股东完成增持计划，实际增持约5亿元

Core Points - Shanghai Laishi (002252) announced that its controlling shareholder, Haiyingkang (Qingdao) Medical Technology Co., Ltd., has completed its shareholding increase plan as of the announcement date [1] - During the increase period, Haiyingkang acquired a total of 72.9353 million shares through the Shenzhen Stock Exchange, representing 1.1% of the company's total share capital, with a total investment of approximately 500 million yuan [1] - Following this increase, Haiyingkang and its concerted parties hold a total of 1.9885 billion shares in Shanghai Laishi, accounting for 29.9% of the total shareholding [1]